schliessen

Filtern

 

Bibliotheken

Type 2 diabetes

Summary 415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distr... Full description

Journal Title: The Lancet (British edition) 2017, Vol.389 (10085), p.2239-2251
Main Author: Chatterjee, Sudesna, MD
Other Authors: Khunti, Kamlesh, Prof , Davies, Melanie J, Prof
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 0140-6736
Link: https://www.ncbi.nlm.nih.gov/pubmed/28190580
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_1867981590
title: Type 2 diabetes
format: Article
creator:
  • Chatterjee, Sudesna, MD
  • Khunti, Kamlesh, Prof
  • Davies, Melanie J, Prof
subjects:
  • Abridged Index Medicus
  • Blood Glucose - metabolism
  • Cardiovascular disease
  • Complications
  • Diabetes
  • Diabetes mellitus
  • Diabetes mellitus (non-insulin dependent)
  • Diabetes Mellitus, Type 2 - complications
  • Diabetes Mellitus, Type 2 - diagnosis
  • Diabetes Mellitus, Type 2 - epidemiology
  • Diabetes Mellitus, Type 2 - therapy
  • Diabetics
  • Diagnosis
  • Early Diagnosis
  • Endocrinology
  • Genotypes
  • Health aspects
  • Health Promotion - methods
  • Health risk assessment
  • Humans
  • Hypoglycemic Agents - therapeutic use
  • Incidence
  • Insulin resistance
  • Internal Medicine
  • Management
  • Mass Screening - methods
  • Maturity
  • Medical colleges
  • Medical screening
  • Microvasculature
  • Morbidity
  • Mortality
  • Obesity - complications
  • Obesity - therapy
  • Patients
  • Phenotypes
  • Prevention
  • Randomized Controlled Trials as Topic
  • Risk analysis
  • Risk factors
  • Screening
  • Type 2 diabetes
ispartof: The Lancet (British edition), 2017, Vol.389 (10085), p.2239-2251
description: Summary 415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on health-care systems. Despite increasing knowledge regarding risk factors for type 2 diabetes and evidence for successful prevention programmes, the incidence and prevalence of the disease continues to rise globally. Early detection through screening programmes and the availability of safe and effective therapies reduces morbidity and mortality by preventing or delaying complications. Increased understanding of specific diabetes phenotypes and genotypes might result in more specific and tailored management of patients with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young. In this Seminar, we describe recent developments in the diagnosis and management of type 2 diabetes, existing controversies, and future directions of care.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.8898299
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_1867981590
sourceformatXML
sourcesystemPC
galeidA497950751
sourcerecordidA497950751
originalsourceidFETCH-LOGICAL-c721t-93acfc39c6158243658ec6e558af3845aba1dbdc7bd82afc25b0dca4543388163
addsrcrecordideNqNkl1r1EAUhgdR7FrFX6AUvKlg6pz5DoJSil9Q8MIK3g2Tyck6NZtsM4mw_97Jrm7TZWnLQAaG533mDHkJeQH0BCiot98pCJopzdUx6NecUmky9oDMQGiRSaF_PiSzLXJAnsR4SSkVisrH5IAZyFOAzsjzi9USj9hRGVyBPcan5FHl6ojP_u2H5MenjxdnX7Lzb5-_np2eZ14z6LOcO195nnsF0jDBlTToFUppXMWNkK5wUBal10VpmKs8kwUtvRNScG4MKH5IjjfeZddeDRh7uwjRY127BtshWjBK5wZkThP6age9bIeuSdNZxkEbDZSZ26j0VmE4Uxyuqbmr0YamavvO-fFqeyoZSK018FspketcUi1H18keKq0SF8G3DVYhnd_Q3iswveHlnoCdGvcCU8ObCVAMMTQY0yeG-a8-zt0Q480J74FP7XKD-66NscPKLruwcN3KArVjS-26pXasoAVt1y1NP2079nIoFlhuU_9rmYB3O2IfeteHtknvC_Wd-g-bNKYC_wnY2egDNh7L0KHvbdmGOw3vdwy-Dk3wrv6NK4zXzbKRWbqRjA7QawPjfwEephJV
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid1904832631
display
typearticle
titleType 2 diabetes
sourceAlma/SFX Local Collection
creatorChatterjee, Sudesna, MD ; Khunti, Kamlesh, Prof ; Davies, Melanie J, Prof
creatorcontribChatterjee, Sudesna, MD ; Khunti, Kamlesh, Prof ; Davies, Melanie J, Prof
descriptionSummary 415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on health-care systems. Despite increasing knowledge regarding risk factors for type 2 diabetes and evidence for successful prevention programmes, the incidence and prevalence of the disease continues to rise globally. Early detection through screening programmes and the availability of safe and effective therapies reduces morbidity and mortality by preventing or delaying complications. Increased understanding of specific diabetes phenotypes and genotypes might result in more specific and tailored management of patients with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young. In this Seminar, we describe recent developments in the diagnosis and management of type 2 diabetes, existing controversies, and future directions of care.
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2DOI: 10.1016/S0140-6736(17)30058-2
3PMID: 28190580
languageeng
publisherEngland: Elsevier Ltd
subjectAbridged Index Medicus ; Blood Glucose - metabolism ; Cardiovascular disease ; Complications ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - therapy ; Diabetics ; Diagnosis ; Early Diagnosis ; Endocrinology ; Genotypes ; Health aspects ; Health Promotion - methods ; Health risk assessment ; Humans ; Hypoglycemic Agents - therapeutic use ; Incidence ; Insulin resistance ; Internal Medicine ; Management ; Mass Screening - methods ; Maturity ; Medical colleges ; Medical screening ; Microvasculature ; Morbidity ; Mortality ; Obesity - complications ; Obesity - therapy ; Patients ; Phenotypes ; Prevention ; Randomized Controlled Trials as Topic ; Risk analysis ; Risk factors ; Screening ; Type 2 diabetes
ispartofThe Lancet (British edition), 2017, Vol.389 (10085), p.2239-2251
rights
0Elsevier Ltd
12017 Elsevier Ltd
2Copyright © 2017 Elsevier Ltd. All rights reserved.
3COPYRIGHT 2017 Elsevier B.V.
4Copyright Elsevier Limited Jun 3, 2017
52017. Elsevier Ltd
lds50peer_reviewed
citedbyFETCH-LOGICAL-c721t-93acfc39c6158243658ec6e558af3845aba1dbdc7bd82afc25b0dca4543388163
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28190580$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Chatterjee, Sudesna, MD
1Khunti, Kamlesh, Prof
2Davies, Melanie J, Prof
title
0Type 2 diabetes
1The Lancet (British edition)
addtitleLancet
descriptionSummary 415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on health-care systems. Despite increasing knowledge regarding risk factors for type 2 diabetes and evidence for successful prevention programmes, the incidence and prevalence of the disease continues to rise globally. Early detection through screening programmes and the availability of safe and effective therapies reduces morbidity and mortality by preventing or delaying complications. Increased understanding of specific diabetes phenotypes and genotypes might result in more specific and tailored management of patients with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young. In this Seminar, we describe recent developments in the diagnosis and management of type 2 diabetes, existing controversies, and future directions of care.
subject
0Abridged Index Medicus
1Blood Glucose - metabolism
2Cardiovascular disease
3Complications
4Diabetes
5Diabetes mellitus
6Diabetes mellitus (non-insulin dependent)
7Diabetes Mellitus, Type 2 - complications
8Diabetes Mellitus, Type 2 - diagnosis
9Diabetes Mellitus, Type 2 - epidemiology
10Diabetes Mellitus, Type 2 - therapy
11Diabetics
12Diagnosis
13Early Diagnosis
14Endocrinology
15Genotypes
16Health aspects
17Health Promotion - methods
18Health risk assessment
19Humans
20Hypoglycemic Agents - therapeutic use
21Incidence
22Insulin resistance
23Internal Medicine
24Management
25Mass Screening - methods
26Maturity
27Medical colleges
28Medical screening
29Microvasculature
30Morbidity
31Mortality
32Obesity - complications
33Obesity - therapy
34Patients
35Phenotypes
36Prevention
37Randomized Controlled Trials as Topic
38Risk analysis
39Risk factors
40Screening
41Type 2 diabetes
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2017
recordtypearticle
recordideNqNkl1r1EAUhgdR7FrFX6AUvKlg6pz5DoJSil9Q8MIK3g2Tyck6NZtsM4mw_97Jrm7TZWnLQAaG533mDHkJeQH0BCiot98pCJopzdUx6NecUmky9oDMQGiRSaF_PiSzLXJAnsR4SSkVisrH5IAZyFOAzsjzi9USj9hRGVyBPcan5FHl6ojP_u2H5MenjxdnX7Lzb5-_np2eZ14z6LOcO195nnsF0jDBlTToFUppXMWNkK5wUBal10VpmKs8kwUtvRNScG4MKH5IjjfeZddeDRh7uwjRY127BtshWjBK5wZkThP6age9bIeuSdNZxkEbDZSZ26j0VmE4Uxyuqbmr0YamavvO-fFqeyoZSK018FspketcUi1H18keKq0SF8G3DVYhnd_Q3iswveHlnoCdGvcCU8ObCVAMMTQY0yeG-a8-zt0Q480J74FP7XKD-66NscPKLruwcN3KArVjS-26pXasoAVt1y1NP2079nIoFlhuU_9rmYB3O2IfeteHtknvC_Wd-g-bNKYC_wnY2egDNh7L0KHvbdmGOw3vdwy-Dk3wrv6NK4zXzbKRWbqRjA7QawPjfwEephJV
startdate2017
enddate2017
creator
0Chatterjee, Sudesna, MD
1Khunti, Kamlesh, Prof
2Davies, Melanie J, Prof
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BKMMT
9BSHEE
100TT
110TZ
120U~
133V.
147QL
157QP
167RV
177TK
187U7
197U9
207X7
217XB
2288A
2388C
2488E
2588G
2688I
278AF
288AO
298C1
308C2
318FE
328FH
338FI
348FJ
358FK
368G5
37ABUWG
38AN0
39ASE
40AZQEC
41BBNVY
42BEC
43BENPR
44BHPHI
45C1K
46DWQXO
47FPQ
48FYUFA
49GHDGH
50GNUQQ
51GUQSH
52H94
53HCIFZ
54K6X
55K9-
56K9.
57KB0
58KB~
59LK8
60M0R
61M0S
62M0T
63M1P
64M2M
65M2O
66M2P
67M7N
68M7P
69MBDVC
70NAPCQ
71PQEST
72PQQKQ
73PQUKI
74Q9U
75S0X
767X8
sort
creationdate2017
titleType 2 diabetes
authorChatterjee, Sudesna, MD ; Khunti, Kamlesh, Prof ; Davies, Melanie J, Prof
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c721t-93acfc39c6158243658ec6e558af3845aba1dbdc7bd82afc25b0dca4543388163
rsrctypearticles
prefilterarticles
languageeng
creationdate2017
topic
0Abridged Index Medicus
1Blood Glucose - metabolism
2Cardiovascular disease
3Complications
4Diabetes
5Diabetes mellitus
6Diabetes mellitus (non-insulin dependent)
7Diabetes Mellitus, Type 2 - complications
8Diabetes Mellitus, Type 2 - diagnosis
9Diabetes Mellitus, Type 2 - epidemiology
10Diabetes Mellitus, Type 2 - therapy
11Diabetics
12Diagnosis
13Early Diagnosis
14Endocrinology
15Genotypes
16Health aspects
17Health Promotion - methods
18Health risk assessment
19Humans
20Hypoglycemic Agents - therapeutic use
21Incidence
22Insulin resistance
23Internal Medicine
24Management
25Mass Screening - methods
26Maturity
27Medical colleges
28Medical screening
29Microvasculature
30Morbidity
31Mortality
32Obesity - complications
33Obesity - therapy
34Patients
35Phenotypes
36Prevention
37Randomized Controlled Trials as Topic
38Risk analysis
39Risk factors
40Screening
41Type 2 diabetes
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Chatterjee, Sudesna, MD
1Khunti, Kamlesh, Prof
2Davies, Melanie J, Prof
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Gale General OneFile (A&I only)
8Academic OneFile (A&I only)
9News PRO
10Pharma and Biotech Premium PRO
11Global News & ABI/Inform Professional
12ProQuest Central (Corporate)
13Bacteriology Abstracts (Microbiology B)
14Calcium & Calcified Tissue Abstracts
15Nursing & Allied Health Database
16Neurosciences Abstracts
17Toxicology Abstracts
18Virology and AIDS Abstracts
19Health & Medical Collection
20ProQuest Central (purchase pre-March 2016)
21Biology Database (Alumni Edition)
22Healthcare Administration Database (Alumni)
23Medical Database (Alumni Edition)
24Psychology Database (Alumni)
25Science Database (Alumni Edition)
26STEM Database
27ProQuest Pharma Collection
28Public Health Database
29Lancet Titles
30ProQuest SciTech Collection
31ProQuest Natural Science Collection
32Hospital Premium Collection
33Hospital Premium Collection (Alumni Edition)
34ProQuest Central (Alumni) (purchase pre-March 2016)
35Research Library (Alumni Edition)
36ProQuest Central (Alumni Edition)
37British Nursing Database
38British Nursing Index
39ProQuest Central Essentials
40Biological Science Collection
41eLibrary
42ProQuest Central
43Natural Science Collection
44Environmental Sciences and Pollution Management
45ProQuest Central Korea
46British Nursing Index (BNI) (1985 to Present)
47Health Research Premium Collection
48Health Research Premium Collection (Alumni)
49ProQuest Central Student
50Research Library Prep
51AIDS and Cancer Research Abstracts
52SciTech Premium Collection
53British Nursing Index
54Consumer Health Database (Alumni Edition)
55ProQuest Health & Medical Complete (Alumni)
56Nursing & Allied Health Database (Alumni Edition)
57ProQuest Newsstand Professional
58ProQuest Biological Science Collection
59Consumer Health Database
60Health & Medical Collection (Alumni Edition)
61Healthcare Administration Database
62Medical Database
63Psychology Database
64Research Library
65Science Database
66Algology Mycology and Protozoology Abstracts (Microbiology C)
67Biological Science Database
68Research Library (Corporate)
69Nursing & Allied Health Premium
70ProQuest One Academic Eastern Edition
71ProQuest One Academic
72ProQuest One Academic UKI Edition
73ProQuest Central Basic
74SIRS Editorial
75MEDLINE - Academic
jtitleThe Lancet (British edition)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Chatterjee, Sudesna, MD
1Khunti, Kamlesh, Prof
2Davies, Melanie J, Prof
formatjournal
genrearticle
ristypeJOUR
atitleType 2 diabetes
jtitleThe Lancet (British edition)
addtitleLancet
date2017
risdate2017
volume389
issue10085
spage2239
epage2251
pages2239-2251
issn0140-6736
eissn1474-547X
abstractSummary 415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on health-care systems. Despite increasing knowledge regarding risk factors for type 2 diabetes and evidence for successful prevention programmes, the incidence and prevalence of the disease continues to rise globally. Early detection through screening programmes and the availability of safe and effective therapies reduces morbidity and mortality by preventing or delaying complications. Increased understanding of specific diabetes phenotypes and genotypes might result in more specific and tailored management of patients with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young. In this Seminar, we describe recent developments in the diagnosis and management of type 2 diabetes, existing controversies, and future directions of care.
copEngland
pubElsevier Ltd
pmid28190580
doi10.1016/S0140-6736(17)30058-2